SEC Form 4 · accession 0001127602-17-009393
LEXICON PHARMACEUTICALS, INC. · LXRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lonnel Coats
Officer — President and CEO · Director
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 6:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2017 | M | 10,836 | — | A | 17,635 | D | |
| Common StockF1 | Feb 28, 2017 | M | 8,390 | — | A | 26,025 | D | |
| Common Stock | Feb 28, 2017 | F | 5,258 | $16.45 | D | 20,767 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (Phantom Stock)F1,F3 | — | Feb 28, 2017 | M | 10,836 | D | — | — | Common Stock | 10,836 | 21,671 | D |
| Restricted Stock Units (Phantom Stock)F1,F4 | — | Feb 28, 2017 | M | 8,390 | D | — | — | Common Stock | 8,390 | 25,170 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- F3Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- F4Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.